Home

Glaxosmithkline Pharmaceuticals Ltd ISIN Code

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

ISIN

INE159A01016

Last updated on: Feb 23, 2025

Key Highlights

  • The ISIN of Glaxosmithkline Pharmaceuticals Ltd is INE159A01016 as of 23 Feb 15:14 PM .
  • The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2508 as of 21 Feb 15:30 .
Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Share Price

₹ 2508.8

-60.65 (-2.36%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20252508.8
20 Feb 20252569.45
19 Feb 20252510.2
18 Feb 20252529.7
17 Feb 20252332.25
14 Feb 20252017.75
13 Feb 20251995.65
12 Feb 20252031.5
11 Feb 20252056.25
10 Feb 20252141.55

ISIN Codes For Similar Companies

Company Name
leftISIN Coderight
Cipla LtdINE059A01026
Dr Reddys Laboratories LtdINE089A01031
Torrent Pharmaceuticals LtdINE685A01028
Sun Pharmaceuticals Industries LtdINE044A01036
Divis Laboratories LtdINE361B01024

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting

Read more

29 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for ISIN of Glaxosmithkline Pharmaceuticals Ltd

What is the ISIN code for Glaxosmithkline Pharmaceuticals Ltd?

The ISIN code for Glaxosmithkline Pharmaceuticals Ltd is INE159A01016. This International Security Identification Number is used to distinguish Glaxosmithkline Pharmaceuticals Ltd's securities in the global market.

Why is Glaxosmithkline Pharmaceuticals Ltd ISIN code important?

The ISIN code is vital for accurately tracking and trading Glaxosmithkline Pharmaceuticals Ltd shares and other securities. It ensures that each security is uniquely identifiable and reduces the risk of errors during transactions.

Can the ISIN code for Glaxosmithkline Pharmaceuticals Ltd change?

The ISIN code itself does not change for a company's existing securities unless Glaxosmithkline Pharmaceuticals Ltd issues new types of securities, which will have different ISIN codes.

Can I use the ISIN code for trading Glaxosmithkline Pharmaceuticals Ltd shares?

Yes, you can use the ISIN code to trade Glaxosmithkline Pharmaceuticals Ltd shares on stock exchanges and also for settlement purposes. The ISIN code helps in precisely identifying the shares you want to trade.

How can I verify the ISIN code for Glaxosmithkline Pharmaceuticals Ltd?

You can verify Glaxosmithkline Pharmaceuticals Ltd ISIN code through financial applications and stock exchange websites. Ensure the ISIN code matches the one provided by the official sources.

What happens if Glaxosmithkline Pharmaceuticals Ltd issues new securities?

If Glaxosmithkline Pharmaceuticals Ltd issues new securities, each new issuance will be assigned a unique ISIN code. This ensures that new and existing securities are properly distinguished and traded.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions